Pricing Log in Create free account

Biora Therapeutics, Inc. (BIORQ) vs PMGC Holdings Inc. (ELAB)

Biora Therapeutics, Inc. and PMGC Holdings Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and PMGC Holdings Inc. are of similar size ($2.5M and $2.5M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against 5.41%. PMGC Holdings Inc. has the higher net margin (−523.0% vs −3,527.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Biora Therapeutics, Inc. leads on 7 and PMGC Holdings Inc. on 7.

Valuation

Metric BIORQ ELAB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.52 9.71
P/B n/m 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.53 0.64
EV/Sales 67.44 (6.66) 9.21
Earnings yield 0.00% (38,441.73%) (33.15%)
Free cash flow yield 0.00% (665.71%) (25.50%)

Profitability

Metric BIORQ ELAB Biotechnology median
Gross margin 85.79% 31.08% 65.16%
Operating margin (6,809.06%) (458.63%) 0.00%
Net margin (3,527.85%) (522.99%) 0.00%
Free cash flow margin (5,165.88%) (348.69%) 0.00%
Return on equity 27.98% (104.60%) (56.36%)
Return on assets (128.19%) (58.71%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BIORQ ELAB Biotechnology median
Revenue growth (TTM) 347.00% 5.41% 6.02%
EPS growth (last fiscal year) (57.40%) 94.22% 30.26%
Revenue growth, 5-year CAGR (87.44%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BIORQ ELAB Biotechnology median
Debt to equity (0.18) 0.02 0.00
Current ratio 0.05 1.36 4.72
Net debt to EBITDA (0.47) 0.87 0.96

Dividend

Metric BIORQ ELAB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIORQ ELAB Biotechnology median
Market cap 2.49m 2.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack